Piacquad David 4
4 · Neumora Therapeutics, Inc. · Filed Sep 18, 2023
Insider Transaction Report
Form 4
Piacquad David
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-09-14+46,455→ 46,455 totalExercise: $17.00Exp: 2033-09-13→ Common Stock (46,455 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option vest on each monthly anniversary measured from September 8, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.